SG11201709654YA - Bisamide derivative of dicarboxylic acid as an agent for stimulating tissue regeneration and recovery of diminished tissue function - Google Patents

Bisamide derivative of dicarboxylic acid as an agent for stimulating tissue regeneration and recovery of diminished tissue function

Info

Publication number
SG11201709654YA
SG11201709654YA SG11201709654YA SG11201709654YA SG11201709654YA SG 11201709654Y A SG11201709654Y A SG 11201709654YA SG 11201709654Y A SG11201709654Y A SG 11201709654YA SG 11201709654Y A SG11201709654Y A SG 11201709654YA SG 11201709654Y A SG11201709654Y A SG 11201709654YA
Authority
SG
Singapore
Prior art keywords
recovery
agent
dicarboxylic acid
diminished
stimulating
Prior art date
Application number
SG11201709654YA
Other languages
English (en)
Inventor
Vladimir Evgenievich Nebolsin
Anastasia Vladimirovna Rydlovskaya
Alexandr Mikhailovich Dygai
Tatiana Gennadievna Borovskaya
Evgenii Germanovich Skurikhin
Original Assignee
Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises”
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” filed Critical Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises”
Publication of SG11201709654YA publication Critical patent/SG11201709654YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/417Imidazole-alkylamines, e.g. histamine, phentolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201709654YA 2015-05-27 2016-05-26 Bisamide derivative of dicarboxylic acid as an agent for stimulating tissue regeneration and recovery of diminished tissue function SG11201709654YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2015120055A RU2647438C2 (ru) 2015-05-27 2015-05-27 Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей
PCT/RU2016/050015 WO2016190785A1 (ru) 2015-05-27 2016-05-26 Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей

Publications (1)

Publication Number Publication Date
SG11201709654YA true SG11201709654YA (en) 2017-12-28

Family

ID=57393489

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201709654YA SG11201709654YA (en) 2015-05-27 2016-05-26 Bisamide derivative of dicarboxylic acid as an agent for stimulating tissue regeneration and recovery of diminished tissue function

Country Status (17)

Country Link
US (2) US10076511B2 (es)
EP (1) EP3305286A4 (es)
JP (1) JP6700312B2 (es)
KR (1) KR102174191B1 (es)
CN (1) CN108024978B (es)
AU (1) AU2016266439B2 (es)
BR (1) BR112017025283A2 (es)
CA (1) CA2986911C (es)
EA (1) EA034437B1 (es)
HK (1) HK1247126A1 (es)
IL (1) IL255899B (es)
MA (1) MA45829A (es)
MX (1) MX2017015192A (es)
RU (2) RU2647438C2 (es)
SG (1) SG11201709654YA (es)
UA (1) UA122336C2 (es)
WO (1) WO2016190785A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2647438C2 (ru) * 2015-05-27 2018-03-15 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей
IL267077B (en) * 2017-05-26 2022-07-01 Obschestvo S Ogranichennoi Otvetstvennostiyu Pharmenterprises New glutaminyl cyclase inhibitors and their use in the treatment of various diseases
RU2662559C1 (ru) * 2017-10-27 2018-07-26 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Новый ингибитор глутаминилциклаз и его применение для лечения заболеваний легких и дыхательных путей
WO2023177328A1 (en) 2022-03-17 2023-09-21 Treamid Therapeutics Gmbh Bisamide derivative of dicarboxylic acid for use in restoring the external respiratory function after coronavirus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2665688C2 (ru) * 2013-04-12 2018-09-04 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения
RU2647438C2 (ru) * 2015-05-27 2018-03-15 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей
IL267077B (en) 2017-05-26 2022-07-01 Obschestvo S Ogranichennoi Otvetstvennostiyu Pharmenterprises New glutaminyl cyclase inhibitors and their use in the treatment of various diseases

Also Published As

Publication number Publication date
MX2017015192A (es) 2018-08-01
EP3305286A1 (en) 2018-04-11
EP3305286A4 (en) 2019-06-12
CN108024978A (zh) 2018-05-11
RU2017144851A (ru) 2019-06-27
EA201792565A1 (ru) 2018-04-30
KR20180035739A (ko) 2018-04-06
BR112017025283A2 (pt) 2018-08-07
US10772870B2 (en) 2020-09-15
MA45829A (fr) 2019-06-12
RU2017144851A3 (es) 2019-07-17
EA034437B1 (ru) 2020-02-07
RU2727142C2 (ru) 2020-07-21
JP2018515584A (ja) 2018-06-14
HK1247126A1 (zh) 2018-09-21
IL255899B (en) 2022-04-01
US20180147184A1 (en) 2018-05-31
AU2016266439B2 (en) 2020-05-14
UA122336C2 (uk) 2020-10-26
RU2647438C2 (ru) 2018-03-15
JP6700312B2 (ja) 2020-05-27
AU2016266439A1 (en) 2018-01-25
CA2986911C (en) 2020-06-23
CA2986911A1 (en) 2016-12-01
CN108024978B (zh) 2020-11-20
KR102174191B1 (ko) 2020-11-05
US20180353479A1 (en) 2018-12-13
RU2015120055A (ru) 2016-12-20
US10076511B2 (en) 2018-09-18
WO2016190785A1 (ru) 2016-12-01
IL255899A (en) 2018-01-31

Similar Documents

Publication Publication Date Title
HK1252688A1 (zh) 製備膽汁酸及其衍生物的方法
HK1251181A1 (zh) 組織修復和再生方法
HK1232120A1 (zh) 喹啉衍生物用於治療軟組織肉瘤的方法和用途以及用於治療軟組織肉瘤的藥物組合物
HK1254055A1 (zh) 製備奧貝膽酸及其衍生物的方法
HK1247126A1 (zh) 二羧酸的雙酰胺衍生物作爲用於刺激組織再生和恢復減退的組織功能的藥劑
IL256971A (en) Methods for preparation of bile acids and derivatives thereof
PL3157531T3 (pl) Sposoby i kompozycje do stymulacji jelitowego układu enteroendokrynnego w leczeniu chorób lub stanów związanych z tym układem
GB201521581D0 (en) Methods of purifying nanostructures
IL248251A0 (en) Systems and methods for regeneration of basic aqueous solution
HK1248537A1 (zh) 使用茚滿乙酸衍生物治療肝病的方法
IL257247A (en) Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
EP3276013A4 (en) Agent for adsorption of ruthenium from aqueous solution and method for adsorption of ruthenium from aqueous solution
HK1246279A1 (zh) C14-位羥基酯化的雷公藤甲素氨基酸衍生物、及其製備方法和應用
HUE061332T2 (hu) Eljárás aminobenzoesav vagy aminobenzoesav-származék elõállítására
ZA201800720B (en) Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
PT3116880T (pt) Macrociclos de ácido piridin-3-il acético como inibidores da replicação do vírus da imunodeficiência humana
IL257157A (en) Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
IL256450A (en) Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
KR101747541B9 (ko) 키토올리고당을 함유하는 피부조직재생용 세포담체 및 그 제조방법
HK1232209A1 (zh) 製備 -乙酰氧基丙酸及其衍生物的方法
IL256452A (en) Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
IL256449A (en) Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
IL256407A (en) Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
SG11201705684SA (en) Recovery of acetic acid